Iona Munjal | Executive Director, Vaccine Clinical Research and Development
pfizer

Iona Munjal, MD FAAP, is a seasoned leader in the pharmaceutical industry, currently serving as the Vice President of Pfizer Vaccines. With over 15 years of experience in vaccine development and commercialization, Iona has a proven track record of driving innovation and strategic growth in the global healthcare sector. She is known for her expertise in navigating complex regulatory landscapes, forging strategic partnerships, and delivering life-saving vaccines to communities worldwide.

Throughout her career, Iona has been at the forefront of cutting-edge research and development initiatives, leading cross-functional teams to bring novel vaccine candidates from concept to market, including maternal immunization. Her deep understanding of market dynamics and patient needs has enabled her to shape successful commercialization strategies that maximize the impact of Pfizer's vaccine portfolio with strategic oversight of several large global assets including the RSV and Group B Streptococcal programs. 

Iona is a passionate advocate for public health and has been instrumental in driving initiatives to increase access to vaccines in underserved populations. She is committed to advancing global health security through the development of innovative vaccine solutions that address emerging infectious diseases and pandemic threats.

As a speaker at the World Vaccine Congress Washington 2025, Iona Munjal will share her insights on R&D and strategic partnering for the global vaccine industry.